Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03338049 · ClinicalTrials.gov registry record · NA

All in One Study: A Prospective Trial of Electromagnetic Navigation for Biopsy of Pulmonary Nodules

A NA study of Lung Cancer, sponsored by Veran Medical Technologies.

Completed
Registry status
NA
Development phase
150
Enrollment target
9
Study locations

NCT03338049: Completed NA study of Lung Cancer, sponsored by Veran Medical Technologies.

NCT03338049 is a NA study of Lung Cancer that has completed, run by Veran Medical Technologies. The registered enrollment target is 150 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (84% lower). The trial reports 9 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03338049, a NA study of Lung Cancer, has completed, sponsored by Veran Medical Technologies.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target
9
Study locations

Study Summary

This is a multi-center, non-randomized, single-arm, prospective trial to evaluate a staged sampling methodology designed to maximize the diagnostic yield of lung biopsy in a single procedure setting.

Conditions Studied

Lung Cancer

Interventions

  • DEVICE Veran System

Study Locations (9)

North Carolina

  • University of North Carolina Medical Center - Chapel Hill
  • Duke University Hospital - Durham

Arizona

  • Banner University Medical Center - Phoenix - Phoenix

Georgia

  • Grady Memorial Hospital - Atlanta

Maryland

  • Johns Hopkins Hospital - Baltimore

Missouri

  • Washington University Medical Center - St Louis

Pennsylvania

  • University of Pittsburgh Medical Center - Pittsburgh

South Carolina

  • Medical University of South Carolina Medical Center - Charleston

Washington

  • Swedish Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2018-02-14
Est. Completion 2019-12-01
Phase NA

Sponsor

Veran Medical Technologies

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03338049

The ClinicalTrials.gov registry entry for NCT03338049 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (84% lower). The listed sponsor is Veran Medical Technologies, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Veran System is the first listed.

NCT03338049 reports 9 study locations spanning 8 distinct geographic areas - top geographies include North Carolina, Arizona, Georgia.

Frequently Asked Questions

What is clinical trial NCT03338049 about?

NCT03338049 is a clinical study titled "All in One Study: A Prospective Trial of Electromagnetic Navigation for Biopsy of Pulmonary Nodules". This is a multi-center, non-randomized, single-arm, prospective trial to evaluate a staged sampling methodology designed to maximize the diagnostic yield of lung biopsy in a single procedure setting.

What is the current status of trial NCT03338049?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2018-02-14. Estimated completion is 2019-12-01.

What conditions does trial NCT03338049 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT03338049?

The interventions under investigation include: Veran System (DEVICE).

Who is sponsoring clinical trial NCT03338049?

This trial is sponsored by Veran Medical Technologies, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03338049 being conducted?

This trial has 9 study locations across Arizona, Georgia, Maryland, Missouri, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Cancer

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.